CA2656823C - Cyanocobalamin low viscosity aqueous formulations for intranasal delivery - Google Patents

Cyanocobalamin low viscosity aqueous formulations for intranasal delivery Download PDF

Info

Publication number
CA2656823C
CA2656823C CA2656823A CA2656823A CA2656823C CA 2656823 C CA2656823 C CA 2656823C CA 2656823 A CA2656823 A CA 2656823A CA 2656823 A CA2656823 A CA 2656823A CA 2656823 C CA2656823 C CA 2656823C
Authority
CA
Canada
Prior art keywords
cyanocobalamin
solution
concentration
spray
droplets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2656823A
Other languages
English (en)
French (fr)
Other versions
CA2656823A1 (en
Inventor
Steven C. Quay
Zenaida O. Go
Peter C. Aprile
Antony P. Sileno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Par Pharmaceuticals Inc
Original Assignee
Par Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Par Pharmaceuticals Inc filed Critical Par Pharmaceuticals Inc
Priority to CA2863377A priority Critical patent/CA2863377C/en
Publication of CA2656823A1 publication Critical patent/CA2656823A1/en
Application granted granted Critical
Publication of CA2656823C publication Critical patent/CA2656823C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2656823A 2006-06-23 2006-06-23 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery Expired - Fee Related CA2656823C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2863377A CA2863377C (en) 2006-06-23 2006-06-23 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/024685 WO2007149098A1 (en) 2006-06-23 2006-06-23 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2863377A Division CA2863377C (en) 2006-06-23 2006-06-23 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery

Publications (2)

Publication Number Publication Date
CA2656823A1 CA2656823A1 (en) 2007-12-27
CA2656823C true CA2656823C (en) 2015-02-03

Family

ID=38833714

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2656823A Expired - Fee Related CA2656823C (en) 2006-06-23 2006-06-23 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery

Country Status (10)

Country Link
EP (1) EP2035441A4 (de)
JP (1) JP5769924B2 (de)
KR (3) KR20090074722A (de)
CN (1) CN101600729A (de)
AU (1) AU2006344733B2 (de)
CA (1) CA2656823C (de)
IL (2) IL196038A (de)
NO (1) NO20090368L (de)
WO (1) WO2007149098A1 (de)
ZA (1) ZA200900191B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2686299T3 (es) * 2010-10-29 2018-10-17 Troikaa Pharmaceuticals Ltd Composiciones nasales de vitamina B12
EP3589269B1 (de) * 2017-03-02 2021-04-07 Dutch Renewable Energy B.V. Intranasale verabreichung von physiologisch aktiven stoffen
US20220111162A1 (en) * 2020-07-29 2022-04-14 Lido Ventures Llc Apparatus, system, and method for facilitating intranasal treatment of a patient

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218679B1 (de) * 1985-04-16 1991-12-11 Nastech Pharmaceutical Company, Inc. Aerosolmittel zur nasenverstäubung von vitamin b 12
US4724231A (en) * 1985-04-16 1988-02-09 Nastech Pharmaceutical, Inc. Nasel compositions containing vitamin B12
US5112804A (en) * 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
US4959176A (en) * 1988-04-29 1990-09-25 Beckman Instruments, Inc. High resolution non corrosive amino acid analysis buffer solutions
US5227311A (en) * 1988-10-11 1993-07-13 Abbott Laboratories Intrinsic factor to determine B12
BE1007839A6 (nl) * 1993-12-20 1995-10-31 Merkus Franciscus W H M Prof Farmaceutische compositie voor de nasale toediening van hydroxocobalamine.
US6406730B1 (en) * 1998-12-01 2002-06-18 Carl E. Banyard Process for producing low acid food products
FR2787029A1 (fr) * 1998-12-09 2000-06-16 Biovector Therapeutics Utilisation dans une composition pharmaceutique pour l'administration par voie nasale de vitamine b12 pour la delivrance d'agents actifs au systeme nerveux central
US20040043043A1 (en) * 2000-09-20 2004-03-04 Schlyter Jimmy Hirschsprung Preparation of emulsions and concentrates thereof
US20060074034A1 (en) * 2001-09-17 2006-04-06 Collins Douglas A Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
US6911434B2 (en) * 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
DE10300719A1 (de) * 2003-01-11 2004-07-22 Basf Ag Verbessertes Verfahren zur Herstellung von Vitamin B12
US20060127320A1 (en) * 2004-05-10 2006-06-15 Nastech Pharmaceutical Company Inc. Method of delivering parathyroid hormone to a human
US20060046969A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Antibacterial compositions for drug administration
JP2009504767A (ja) * 2005-08-17 2009-02-05 フレミング・アンド・カンパニー・ファーマシューティカルズ ビタミンb12鼻用スプレーおよび使用方法

Also Published As

Publication number Publication date
IL248447A0 (en) 2016-11-30
IL248447B (en) 2021-10-31
CA2656823A1 (en) 2007-12-27
IL196038A (en) 2016-10-31
KR20090074722A (ko) 2009-07-07
JP5769924B2 (ja) 2015-08-26
NO20090368L (no) 2009-03-23
KR20170098977A (ko) 2017-08-30
JP2009541312A (ja) 2009-11-26
EP2035441A1 (de) 2009-03-18
AU2006344733B2 (en) 2014-02-27
KR20140101010A (ko) 2014-08-18
EP2035441A4 (de) 2013-01-16
IL196038A0 (en) 2009-09-01
WO2007149098A1 (en) 2007-12-27
ZA200900191B (en) 2012-09-26
CN101600729A (zh) 2009-12-09
AU2006344733A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
US20190216842A1 (en) Vitamin b12 nasal spray and method of use
EP3679941B1 (de) Sichere verabreichung von desmopressin
AU2023202420A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
US9415007B2 (en) Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
CA2656823C (en) Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
US20200390691A1 (en) Compositions, devices, and methods for the treatment of overdose and reward-based disorders
US7229636B1 (en) Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
AU2014202415B2 (en) Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
CA2863377C (en) Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
JP6097787B2 (ja) 鼻内送達用シアノコバラミン低粘度水性製剤
JP5797227B2 (ja) 鼻内送達用シアノコバラミン低粘度水性製剤
CA3124202A1 (en) Compositions, devices, and methods for the treatment of overdose and reward-based disorders
Feller et al. Vitamin B 12 nasal spray and method of use

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20220623